PhD, MRes, BSc
I did my PhD at the University of Southampton and the Agency for Science, Technology and Research in Singapore under the supervision of Dr Sylvia Pender and Dr Anis Larbi, studying age-related metabolic adaptations in the immune system. After this, I joined the laboratory of Dr Bethan Psaila and her team to study normal and malignant megakaryocyte/platelet biology.
My research in the Psaila group focuses on studying the immune landscape in patients with myeloproliferative neoplasms (MPNs), specifically understanding how these alterations affect patient responses to immunotherapy. Understanding the role of the immune landscape in MPN is essential for improving treatment options for patients with MPNs.
Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.
Chowdhury O. et al, (2021), Br J Haematol
Changes in T Cell Homeostasis and Vaccine Responses in Old Age
Strickland M. et al, (2021), Vaccines for Older Adults: Current Practices and Future Opportunities
Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathway
Strickland M. et al, (2020), Nature Communications
Relationships Between Ion Channels, Mitochondrial Functions and Inflammation in Human Aging
Strickland M. et al, (2019), Frontiers in Physiology
Metabolic reprogramming in glioma
Strickland M. and Stoll E., (2017), Frontiers in Cell and Developmental Biology